Table 3 Logistic regression analyses for multiple organ involvement in sarcoidosis

Variables

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

Age^a

0.98 (0.95–1.02)

0.339

0.99 (0.94–1.04)

0.716

0.98 (0.93–1.02)

0.300

1.01 (0.95–1.06)

0.815

Sex, male

0.55 (0.18–1.67)

0.293

0.64 (0.15–2.67)

0.537

0.53 (0.13–2.19)

0.383

0.72 (0.16–3.25)

0.664

BMI^b

1.01 (0.82–1.25)

0.930

Serum ACE, ≥ 21.4 IU/L

1.08 (0.99–1.18)

0.096

2.41 (0.64–9.14))

0.196

2.40 (0.64–9.03)

0.195

2.53 (0.62–10.30)

0.195

Radiographic stage, ≥ II

1.27 (0.41–3.95)

0.676

Pulmonary function test

FVC % predicted^c

0.97 (0.93–1.02)

0.240

FEV1/FVC^c

1.00 (0.98–1.01)

0.692

Bronchoalveolar lavage

 Lymphocytes^c

1.01 (0.97–1.04)

0.767

 CD4/CD8 ratio, ≥ 3.5

0.99 (0.29–3.39)

0.992

n-3 PUFAs, high

0.23 (0.07–0.74)

0.013

0.33 (0.09–1.24)

0.101

n-6 PUFAs, high

0.30 (0.09–1.05)

0.059

0.43 (0.11–1.67)

0.225

n-3/n-6 ratio, high

0.16 (0.05–0.53)

0.003

0.14 (0.03–0.61)

0.009

SFAs, high

0.16 (0.03–0.76)

0.022

0.25 (0.05–1.35)

0.107

0.25 (0.05–1.34)

0.105

0.16 (0.03–0.96)

0.045

MUFAs, high

1.00 (0.18–5.69)

1.000